Clinical Trials on Plasmodium Infections in United Kingdom

Total 20151 results

University of Oxford

Completed

Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.

Tuberculosis

United Kingdom
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously

Tuberculosis

United Kingdom
University of Oxford
University of Maryland; Imperial College London; Wellcome Trust

Completed

Understanding Typhoid Disease After Vaccination

Typhoid Fever | Typhoid | Enteric Fever

United Kingdom
University of Oxford

Completed

A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG

Tuberculosis

United Kingdom
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG

Tuberculosis

United Kingdom
University Hospitals, Leicester

Recruiting

Pharmacokinetics of Voriconazole in Adult ECMO Patients

Covid19 | Influenza | Aspergillosis

United Kingdom
St George's, University of London

Unknown

Sources of COmplement in Meningococcal and Pertussis Serum Bactericidal Antibody Assays (COMPAre)

Pertussis | Prematurity | Meningococcal Disease

United Kingdom
University of Oxford

Completed

Study Evaluating Aerosol and Intradermal Administration of a Candidate Tuberculosis (TB) Vaccine, MVA85A, as a Way to Increase Immune Response and Avoid Anti-vector Immunity

Tuberculosis

United Kingdom
St George's, University of London
Novartis Vaccines; Statens Serum Institut; European Union

Terminated

A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6) (TMUVA-01)

Tuberculosis

United Kingdom
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.

Tuberculosis

United Kingdom
Portsmouth Hospitals NHS Trust
Akari Therapuetics

Completed

The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19

Coronavirus

United Kingdom
King's College London
National Health Service, United Kingdom

Enrolling by invitation

Impact of an Enhanced Sterile Protocol on Root Canal Treatment Outcome

Endodontic Disease | Root Canal Infection | Root Canal Treatment

United Kingdom
Kirby Institute
Chelsea and Westminster NHS Foundation Trust

Completed

The Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK)

HIV Infection

Argentina, South Africa, Thailand, United Kingdom
Liverpool School of Tropical Medicine
Merck Sharp & Dohme LLC

Recruiting

Experimental Human Pneumococcal Challenge With SPN3 (Challenge3)

Streptococcus Pneumonia

United Kingdom
University Hospitals Bristol and Weston NHS Foundation...
Public Health England; University of Bristol; Novartis Vaccines; North Bristol...

Completed

Regulation of Mucosal Immune Response to Systemic MenB Vaccine

Meningococcal Infections

United Kingdom
Chelsea and Westminster NHS Foundation Trust
Imperial College London; NEAT ID Foundation; FUJIFILM Toyama Chemical Co., Ltd.

Completed

Early Intervention in COVID-19: Favipiravir Verses Standard Care (PIONEER)

Coronavirus Infection

United Kingdom, Brazil, Mexico
Orlando Health, Inc.
Forest Laboratories

Withdrawn

Ceftaroline in the Treatment of Bone and Joint Infections

Osteomyelitis | Joint Infections

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom (MET52)

Healthy Volunteers (Meningococcal Infection)

United Kingdom
University of Oxford

Completed

Safety and Immunogenicity of a Candidate CHIKV Vaccine (CHIK001)

Chikungunya Fever

United Kingdom
Codagenix, Inc

Completed

Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19

COVID-19

United Kingdom
St George's, University of London

Unknown

Diagnostics of COVID-19/DARTS (Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak)

COVID-19

United Kingdom
University of Oxford
University of Plymouth; Nuffield Trust

Completed

Remote-by-Default Care in the COVID-19 Pandemic

COVID-19

United Kingdom
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge

Completed

Natural Language Processing (NLP) Analysis of Free Text Notes to Investigate Coronavirus (COVID-19)

COVID-19

United Kingdom
4D pharma plc

Withdrawn

A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19

COVID-19

United Kingdom
University Hospital, Geneva
University of Zurich; University of Lausanne

Completed

COVID-19 and Vaccination Attitudes (VACAT)

COVID-19

United Kingdom
Liverpool School of Tropical Medicine
Pfizer

Recruiting

PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2) (Pneumo 2)

Streptococcus Pneumonia

United Kingdom
Chiron Corporation

Unknown

Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine

Meningococcal Disease; Meningococcal Meningitis

United Kingdom
Belfast Health and Social Care Trust

Completed

Procalcitonin in Diagnosis of Bacterial Infections in Young Infants

Sepsis

United Kingdom
Imperial College London
Celgene Corporation

Completed

Spondylitis Trial of Apremilast for Better Rheumatic Therapy (START)

Ankylosing Spondylitis

United Kingdom
University of Edinburgh
University of Oxford; Latus Therapeutics; Scottish National Blood Transfusion...

Recruiting

DEFINE - Evaluating Therapies for COVID-19 (DEFINE)

COVID-19

United Kingdom
Richmond Research Institute
Richmond Pharmacology Limited

Recruiting

Serological and PCR Testing for COVID-19

COVID-19

United Kingdom
LumiraDx UK Limited

Suspended

COVID-19: A POC Test Under Research & Evaluation (CAPTURE)

COVID-19

United Kingdom
University College, London
LifeArc

Completed

FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals (FLARE)

COVID-19

United Kingdom
University of Ulster
University of Dublin, Trinity College; Western Health and Social Care Trust

Completed

COVID RESPONSE STUDY (COVRES) (COVRES)

COVID-19

United Kingdom
The Christie NHS Foundation Trust
Manchester University NHS Foundation Trust; Aptus Clinical Ltd.; Zenzium Ltd.

Completed

COntinuous Signs Monitoring In Covid-19 Patients (COSMIC-19)

COVID-19

United Kingdom
Molecular Partners AG

Terminated

Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)

COVID-19

United Kingdom
Glasgow Royal Infirmary

Unknown

Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection

COVID-19

United Kingdom
Cambridge University Hospitals NHS Foundation Trust

Unknown

PROLIFIC ChemoprophylaxisTrial (COVID-19)

COVID-19

United Kingdom
St George's, University of London
European Society for Paediatric Infectious Diseases

Recruiting

Observational Study of the Management of Infants With Congenital CMV (cCMVnet)

Congenital Cmv

United Kingdom
Cambridge University Hospitals NHS Foundation Trust
University of Liverpool; Cambridge University Hospitals NHS Foundation Trust... and other collaborators

Recruiting

HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID) (HEAL-COVID)

Covid19

United Kingdom
Nottingham University Hospitals NHS Trust

Recruiting

NoRCoRP Assessment Clinic (NoRCoRP)

Covid19

United Kingdom
Imperial College London
Imperial College Healthcare NHS Trust; London North West Healthcare NHS Trust; Chelsea and Westminster Hospital NHS Foundation Trust

Recruiting

Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using Electrocardiograms (AI-COV-19)

Coronavirus

United Kingdom
Nottingham University Hospitals NHS Trust
East Midlands Academic Health Sciences Network

Completed

Optimising Resource Allocation Via Prediction of Outcomes for Covid-19

COVID19

United Kingdom
The Royal Wolverhampton Hospitals NHS Trust

Completed

Evaluating the Impact of COVID-19 (Coronavirus) on Research in Care Homes

Covid19

United Kingdom
Imperial College London
Hvivo

Completed

COVID-19 SARS-CoV-2 Screening Protocol

Covid19

United Kingdom
Great Ormond Street Hospital for Children NHS Foundation...

Unknown

Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19 ((COVID19_BMT))

COVID19

United Kingdom
Queen Mary University of London

Terminated

CICERO- A Care Home Study of COVID-19

COVID

United Kingdom
Lancashire Teaching Hospitals NHS Foundation Trust
NIHR Lancashire Clinical Research Facility

Completed

Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia

Covid19

United Kingdom
Guy's and St Thomas' NHS Foundation Trust

Completed

Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 Infection

Covid19

United Kingdom
King's College London
Guy's and St Thomas' NHS Foundation Trust

Unknown

The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare Workers) (CEDiD)

Covid19

United Kingdom

Clinical Trials on Plasmodium Infections in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations